1. Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropneia in patients with hematological malignancies. Issue 4 (April 2013) Authors: Shinohara, Akihito; Yoshiki, Yumiko; Masamoto, Yosuke; Hangaishi, Akira; Nannya, Yasuhito; Kurokawa, Mineo Journal: Leukemia & lymphoma Issue: Volume 54:Issue 4(2013:Apr.) Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma. (28th November 2019) Authors: Okazuka, Kiyoshi; Ishida, Tadao; Nashimoto, Junichiro; Uto, Yui; Sato, Kota; Miyazaki, Kanji; Ogura, Mizuki; Yoshiki, Yumiko; Abe, Yu; Tsukada, Nobuhiro; Suzuki, Kenshi Journal: European journal of haematology Issue: Volume 104:Number 2(2020) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗